goiter%20nontoxic%20(simple)--%20diffuse%20-and-%20multinodular
GOITER NONTOXIC (SIMPLE): DIFFUSE & MULTINODULAR
Nontoxic goiter is thyroid enlargement unrelated to hypothyroidism, hyperthyroidism, inflammation or neoplasia.
Etiology is usually unknown. Some known causes include iodine deficiency, iodine excess, goitrogen ingestion, autoimmune disorders, thyroid hormone production defects and certain medications.
It is usually asymptomatic.
Symptomatic patient may present with painless neck swelling, cosmetic complaints, shortness of breath, sudden increase in goiter size with pain due to hemorrhage, larger goiter causing obstructive signs eg dysphagia, choking sensation and Pemberton's sign.

Pharmacotherapy

Levothyroxine (T4)

  • May be an alternative to surgery & radioactive iodine therapy
  • More suitable for patients w/o thyroid-stimulating hormone (TSH) suppression or w/ high serum TSH levels
  • Has been used to prevent recurrences after surgery
  • Actions: Suppresses TSH production causing goiter shrinkage
  • Effects based on clinical studies in the management of nontoxic goiter:
    • Goiter size decreases by 25% in 9 months in 51% of patients
  • Not recommended for treatment of nontoxic multinodular goiter due to its low efficacy & risk of thyrotoxicosis
  • Prolonged treatment w/ T4 is required to maintain goiter size reduction & prevent recurrences
    • Prolonged TSH suppression by T4 may also increase risk of bone loss & atrial fibrillation

Radioactive Iodine

  • As an alternative to surgery (especially in elderly, patients unfit for surgery or w/ TSH suppression)
  • Effects based on clinical study in the management of nontoxic goiter:
    • Goiter size decreases by 45% in 2 years in 97% of patients (the greatest reduction in goiter size during the 1st years)
    • Recurrence rate: 8% after 3-5 years
    • Reduces obstructive signs & symptoms (eg tracheal lumen widened by up to 36%; improvement in stridor & dyspnea)
    • Normalize serum TSH w/o causing hypothyroidism
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
25 Aug 2015
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
Roshini Claire Anthony, 07 Nov 2017

Women who are underweight, particularly in their late teens and mid-thirties, may be at risk for early menopause, a recent study found. 

17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.
Audrey Abella, 20 Jan 2017
Diabetes was not a risk factor for total knee replacement (TKR) due to severe knee osteoarthritis, a Singapore study found.